2061 Acellular hyaluronic acid scaffold with growth factor delivery for cartilage repair in a large animal model

OBJECTIVES/SPECIFIC AIMS: Focal cartilage injuries of the knee joint are common and present a treatment challenge due to minimal intrinsic repair. Cartilage tissue engineering techniques currently used in clinical practice are expensive, cumbersome, and often ineffective in patients with mechanical...

Full description

Saved in:
Bibliographic Details
Published inJournal of clinical and translational science Vol. 2; no. S1; p. 3
Main Authors Martín, Anthony R., Patel, Jay M., Zlotnick, Hannah M., Sennet, Mackenzie L., Carey, James L., Mauck, Robert L.
Format Journal Article
LanguageEnglish
Published Cambridge Cambridge University Press 01.06.2018
Subjects
Online AccessGet full text

Cover

Loading…
Abstract OBJECTIVES/SPECIFIC AIMS: Focal cartilage injuries of the knee joint are common and present a treatment challenge due to minimal intrinsic repair. Cartilage tissue engineering techniques currently used in clinical practice are expensive, cumbersome, and often ineffective in patients with mechanical or medical comorbidities. To address these issues, we developed an acellular nanofibrous scaffold with encapsulated growth factors designed to enhanced articular cartilage repair. Our goal is to evaluate this technology in vitro and pilot a large animal model for eventual translation into human subjects. METHODS/STUDY POPULATION: Hyaluronic acid (HA, 65 kDa) will be methacrylated (~40% modification, MeHA) and conjugated with cell-adhesive (RGD) groups. A solution of 4% wt/vol MeHA, 2% wt/vol polyethylene oxide (900 kDa), 0.05% wt/vol Irgacure 2959, and 0.005% wt/vol stromal cell-derived factor-1α (SDF-1α) and/or transforming growth factor-β3 (TGF-β3) will be prepared in ddH 2 O. The solution will be electrospun onto a rotating mandrel to achieve a dry scaffold thickness of 0.5 mm. The scaffold matt will be UV cross-linked and 5 mm-diameter samples will be cut out. Four groups of scaffolds will be prepared: MeHA, MeHA+SDF, MeHA+TGF, MeHA+SDF+TGF. All groups will be evaluated for fiber diameter, swell thickness, equilibrium compressive modulus, degradation rate, and growth factor release rate over 4 weeks (n=10). Scaffolds will also be seeded with juvenile porcine MSCs (5×104) in 200 μL of medium incubated for 24 hours. Seeded scaffolds will be evaluated for equilibrium compressive modulus, cell infiltration, and chondrogenesis at 4 and 8 weeks (n=10). Scaffolds will then be evaluated in a juvenile Yucatan minipig cartilage defect model. In total, 6 animals will undergo bilateral knee surgery to create four 4 mm-diameter full-thickness cartilage defects in each trochlear grove. All defects will receive microfracture to release marrow elements. Each knee will receive 2 scaffolds of the same group (replicates) with paired microfracture controls, resulting in a sample size of 3. Animals will be sacrificed at 12 weeks and defects will be evaluated via non-destructive indentation testing for mechanical properties, microCT for defect fill and subchondral bone morphology, and histology for ICRS II Visual Histological Assessment Scoring. RESULTS/ANTICIPATED RESULTS: Our preliminary studies have shown reliable replication of electrospun MeHA scaffolds. We anticipate cross-linking density to correlate positively with compressive modulus, and negatively with swell thickness, degradation rate, and growth factor release rate. We anticipate the addition of SDF-1α and TGF-β3 to increase cell infiltration and chondrogenesis, respectively, within seeded scaffolds. Similarly, we expect minipig defects treated with growth factor-releasing scaffolds to show greater mechanical properties, defect fill, and ICRS II score compared with MeHA scaffolds without growth factor. DISCUSSION/SIGNIFICANCE OF IMPACT: This study has the potential to show how an HA-based cell-free scaffold can be augmented with 2 growth factors that act synergistically to improve cartilage repair in a large animal model. This technology would improve upon the cell-free scaffolds already used clinically for autologous matrix-induced chondrogenesis and is directly translatable.
AbstractList OBJECTIVES/SPECIFIC AIMS: Focal cartilage injuries of the knee joint are common and present a treatment challenge due to minimal intrinsic repair. Cartilage tissue engineering techniques currently used in clinical practice are expensive, cumbersome, and often ineffective in patients with mechanical or medical comorbidities. To address these issues, we developed an acellular nanofibrous scaffold with encapsulated growth factors designed to enhanced articular cartilage repair. Our goal is to evaluate this technology in vitro and pilot a large animal model for eventual translation into human subjects. METHODS/STUDY POPULATION: Hyaluronic acid (HA, 65 kDa) will be methacrylated (~40% modification, MeHA) and conjugated with cell-adhesive (RGD) groups. A solution of 4% wt/vol MeHA, 2% wt/vol polyethylene oxide (900 kDa), 0.05% wt/vol Irgacure 2959, and 0.005% wt/vol stromal cell-derived factor-1α (SDF-1α) and/or transforming growth factor-β3 (TGF-β3) will be prepared in ddH2O. The solution will be electrospun onto a rotating mandrel to achieve a dry scaffold thickness of 0.5 mm. The scaffold matt will be UV cross-linked and 5 mm-diameter samples will be cut out. Four groups of scaffolds will be prepared: MeHA, MeHA+SDF, MeHA+TGF, MeHA+SDF+TGF. All groups will be evaluated for fiber diameter, swell thickness, equilibrium compressive modulus, degradation rate, and growth factor release rate over 4 weeks (n=10). Scaffolds will also be seeded with juvenile porcine MSCs (5×104) in 200 μL of medium incubated for 24 hours. Seeded scaffolds will be evaluated for equilibrium compressive modulus, cell infiltration, and chondrogenesis at 4 and 8 weeks (n=10). Scaffolds will then be evaluated in a juvenile Yucatan minipig cartilage defect model. In total, 6 animals will undergo bilateral knee surgery to create four 4 mm-diameter full-thickness cartilage defects in each trochlear grove. All defects will receive microfracture to release marrow elements. Each knee will receive 2 scaffolds of the same group (replicates) with paired microfracture controls, resulting in a sample size of 3. Animals will be sacrificed at 12 weeks and defects will be evaluated via non-destructive indentation testing for mechanical properties, microCT for defect fill and subchondral bone morphology, and histology for ICRS II Visual Histological Assessment Scoring. RESULTS/ANTICIPATED RESULTS: Our preliminary studies have shown reliable replication of electrospun MeHA scaffolds. We anticipate cross-linking density to correlate positively with compressive modulus, and negatively with swell thickness, degradation rate, and growth factor release rate. We anticipate the addition of SDF-1α and TGF-β3 to increase cell infiltration and chondrogenesis, respectively, within seeded scaffolds. Similarly, we expect minipig defects treated with growth factor-releasing scaffolds to show greater mechanical properties, defect fill, and ICRS II score compared with MeHA scaffolds without growth factor. DISCUSSION/SIGNIFICANCE OF IMPACT: This study has the potential to show how an HA-based cell-free scaffold can be augmented with 2 growth factors that act synergistically to improve cartilage repair in a large animal model. This technology would improve upon the cell-free scaffolds already used clinically for autologous matrix-induced chondrogenesis and is directly translatable.
OBJECTIVES/SPECIFIC AIMS: Focal cartilage injuries of the knee joint are common and present a treatment challenge due to minimal intrinsic repair. Cartilage tissue engineering techniques currently used in clinical practice are expensive, cumbersome, and often ineffective in patients with mechanical or medical comorbidities. To address these issues, we developed an acellular nanofibrous scaffold with encapsulated growth factors designed to enhanced articular cartilage repair. Our goal is to evaluate this technology in vitro and pilot a large animal model for eventual translation into human subjects. METHODS/STUDY POPULATION: Hyaluronic acid (HA, 65 kDa) will be methacrylated (~40% modification, MeHA) and conjugated with cell-adhesive (RGD) groups. A solution of 4% wt/vol MeHA, 2% wt/vol polyethylene oxide (900 kDa), 0.05% wt/vol Irgacure 2959, and 0.005% wt/vol stromal cell-derived factor-1α (SDF-1α) and/or transforming growth factor-β3 (TGF-β3) will be prepared in ddH 2 O. The solution will be electrospun onto a rotating mandrel to achieve a dry scaffold thickness of 0.5 mm. The scaffold matt will be UV cross-linked and 5 mm-diameter samples will be cut out. Four groups of scaffolds will be prepared: MeHA, MeHA+SDF, MeHA+TGF, MeHA+SDF+TGF. All groups will be evaluated for fiber diameter, swell thickness, equilibrium compressive modulus, degradation rate, and growth factor release rate over 4 weeks (n=10). Scaffolds will also be seeded with juvenile porcine MSCs (5×104) in 200 μL of medium incubated for 24 hours. Seeded scaffolds will be evaluated for equilibrium compressive modulus, cell infiltration, and chondrogenesis at 4 and 8 weeks (n=10). Scaffolds will then be evaluated in a juvenile Yucatan minipig cartilage defect model. In total, 6 animals will undergo bilateral knee surgery to create four 4 mm-diameter full-thickness cartilage defects in each trochlear grove. All defects will receive microfracture to release marrow elements. Each knee will receive 2 scaffolds of the same group (replicates) with paired microfracture controls, resulting in a sample size of 3. Animals will be sacrificed at 12 weeks and defects will be evaluated via non-destructive indentation testing for mechanical properties, microCT for defect fill and subchondral bone morphology, and histology for ICRS II Visual Histological Assessment Scoring. RESULTS/ANTICIPATED RESULTS: Our preliminary studies have shown reliable replication of electrospun MeHA scaffolds. We anticipate cross-linking density to correlate positively with compressive modulus, and negatively with swell thickness, degradation rate, and growth factor release rate. We anticipate the addition of SDF-1α and TGF-β3 to increase cell infiltration and chondrogenesis, respectively, within seeded scaffolds. Similarly, we expect minipig defects treated with growth factor-releasing scaffolds to show greater mechanical properties, defect fill, and ICRS II score compared with MeHA scaffolds without growth factor. DISCUSSION/SIGNIFICANCE OF IMPACT: This study has the potential to show how an HA-based cell-free scaffold can be augmented with 2 growth factors that act synergistically to improve cartilage repair in a large animal model. This technology would improve upon the cell-free scaffolds already used clinically for autologous matrix-induced chondrogenesis and is directly translatable.
Author Zlotnick, Hannah M.
Sennet, Mackenzie L.
Carey, James L.
Martín, Anthony R.
Mauck, Robert L.
Patel, Jay M.
AuthorAffiliation 1 University of Pennsylvania School of Medicine , Philadelphia , PA , USA
3 Translational Musculoskeletal Research Center , Medical Center , University of Pennsylvania , Philadelphia , PA , USA
2 University of Pennsylvania , Philadelphia , PA , USA
AuthorAffiliation_xml – name: 2 University of Pennsylvania , Philadelphia , PA , USA
– name: 3 Translational Musculoskeletal Research Center , Medical Center , University of Pennsylvania , Philadelphia , PA , USA
– name: 1 University of Pennsylvania School of Medicine , Philadelphia , PA , USA
Author_xml – sequence: 1
  givenname: Anthony R.
  surname: Martín
  fullname: Martín, Anthony R.
– sequence: 2
  givenname: Jay M.
  surname: Patel
  fullname: Patel, Jay M.
– sequence: 3
  givenname: Hannah M.
  surname: Zlotnick
  fullname: Zlotnick, Hannah M.
– sequence: 4
  givenname: Mackenzie L.
  surname: Sennet
  fullname: Sennet, Mackenzie L.
– sequence: 5
  givenname: James L.
  surname: Carey
  fullname: Carey, James L.
– sequence: 6
  givenname: Robert L.
  surname: Mauck
  fullname: Mauck, Robert L.
BookMark eNpVkU1rHDEMhk1JoWmaU_-AoceyG43t8XguhRD6EQj00p6NxpZ3vXjHW89Mwv77eruhJCdZ8qtHEu97djHmkRj72MC6gaa7cfO0FtCYtZJv2KWAtl8ZrZuLF-937HqadgBVJbSW8pIdBOiG3zpKaUlY-PaIaSl5jI6ji55PDkPIyfOnOG_5puSnGgK6ORfuKcVHKkceauKwzDHhhnihA8bC48iRV2St4Bj3mPg-144P7G3ANNH1c7xiv799_XX3Y_Xw8_v93e3Dygkh5ErrlkBB0E64IQyqDb6n4EA5A13ftWTQG-Ow6oZAXjpPAwopQDVVFEBesfsz12fc2UOpG5SjzRjtv0IuG3va2CWyPaHqlTCAnVaya9GEbgA5hH7wJrSqsr6cWYdl2JN3NM4F0yvo658xbu0mP1rd9cb0ogI-PQNK_rPQNNtdXspY77eikRrqxdBV1eezypU8TYXC_wkN2JPFtlpsTxZbJeVf5fuc8A
ContentType Journal Article
Copyright The Association for Clinical and Translational Science 2018
The Association for Clinical and Translational Science 2018 2018 The Association for Clinical and Translational Science
Copyright_xml – notice: The Association for Clinical and Translational Science 2018
– notice: The Association for Clinical and Translational Science 2018 2018 The Association for Clinical and Translational Science
DBID AAYXX
CITATION
8FE
8FH
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
GNUQQ
HCIFZ
LK8
M7P
PHGZM
PHGZT
PKEHL
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
5PM
DOA
DOI 10.1017/cts.2018.43
DatabaseName CrossRef
ProQuest SciTech Collection
ProQuest Natural Science Collection
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One Community College
ProQuest Central Korea
ProQuest Central Student
SciTech Premium Collection
ProQuest Biological Science Collection
Biological Science Database
ProQuest Central Premium
ProQuest One Academic
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
ProQuest Central Student
ProQuest Biological Science Collection
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
SciTech Premium Collection
ProQuest One Community College
ProQuest Natural Science Collection
Biological Science Database
ProQuest SciTech Collection
ProQuest Central China
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest One Academic UKI Edition
Natural Science Collection
ProQuest Central Korea
Biological Science Collection
ProQuest Central (New)
ProQuest One Academic
ProQuest One Academic (New)
DatabaseTitleList
CrossRef

ProQuest Central Student
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Open Access Full Text
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
EISSN 2059-8661
EndPage 3
ExternalDocumentID oai_doaj_org_article_9ea494280a764375a8f7b03bf9bd8f54
PMC6798892
10_1017_cts_2018_43
GroupedDBID 09C
09E
0R~
8FE
8FH
AABES
AABWE
AAGFV
AAKTX
AASVR
AAYXX
ABGDZ
ABQTM
ABROB
ABVZP
ABXHF
ACAJB
ACBEK
ACDLN
ACGFS
ACUIJ
ADAZD
ADBBV
ADDNB
ADKIL
ADOVH
ADVJH
AEBAK
AEHGV
AEYHU
AFKQG
AFKRA
AFLVW
AFZFC
AGABE
AGJUD
AHIPN
AHQXX
AHRGI
AIGNW
AIHIV
AIOIP
AJCYY
AKMAY
ALMA_UNASSIGNED_HOLDINGS
ANPSP
AQJOH
ARCSS
AUXHV
AZGZS
BBLKV
BBNVY
BCNDV
BENPR
BHPHI
BLZWO
BMAJL
BRIRG
CBIIA
CCPQU
CCQAD
CFAFE
CITATION
CJCSC
DOHLZ
GROUPED_DOAJ
HCIFZ
HYE
IKXGN
IOEEP
IPYYG
JHPGK
JKPOH
JQKCU
JVRFK
KCGVB
KFECR
LK8
M7P
M~E
NIKVX
OK1
PHGZM
PHGZT
RCA
ROL
RPM
S6U
SAAAG
T9M
WFFJZ
ZYDXJ
AZQEC
DWQXO
GNUQQ
PKEHL
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
5PM
PUEGO
ID FETCH-LOGICAL-c2223-665e040f6c2cbfb45fd9efc04c807975e8ad88ca665bfed3cdeba232041c04f03
IEDL.DBID BENPR
ISSN 2059-8661
IngestDate Wed Aug 27 01:32:45 EDT 2025
Thu Aug 21 18:24:36 EDT 2025
Fri Jul 25 11:49:52 EDT 2025
Tue Jul 01 00:41:35 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue S1
Language English
License http://creativecommons.org/licenses/by/4.0
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c2223-665e040f6c2cbfb45fd9efc04c807975e8ad88ca665bfed3cdeba232041c04f03
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
OpenAccessLink https://doaj.org/article/9ea494280a764375a8f7b03bf9bd8f54
PQID 2136022307
PQPubID 2046292
PageCount 1
ParticipantIDs doaj_primary_oai_doaj_org_article_9ea494280a764375a8f7b03bf9bd8f54
pubmedcentral_primary_oai_pubmedcentral_nih_gov_6798892
proquest_journals_2136022307
crossref_primary_10_1017_cts_2018_43
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20180601
PublicationDateYYYYMMDD 2018-06-01
PublicationDate_xml – month: 06
  year: 2018
  text: 20180601
  day: 01
PublicationDecade 2010
PublicationPlace Cambridge
PublicationPlace_xml – name: Cambridge
– name: Cambridge, UK
PublicationTitle Journal of clinical and translational science
PublicationYear 2018
Publisher Cambridge University Press
Publisher_xml – name: Cambridge University Press
SSID ssj0001826633
Score 2.0305572
Snippet OBJECTIVES/SPECIFIC AIMS: Focal cartilage injuries of the knee joint are common and present a treatment challenge due to minimal intrinsic repair. Cartilage...
SourceID doaj
pubmedcentral
proquest
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage 3
SubjectTerms Basic/Translational Science/Team Science
Cartilage (articular)
Cell adhesion
Chondrogenesis
Computed tomography
Defects
Growth factors
Hyaluronic acid
Knee
Mechanical properties
Polyethylene
Polyethylene oxide
Population studies
Subchondral bone
Surgery
Tissue engineering
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LS8QwEA7iyYsoKq4vcthrNW2TJjmu4iKCnlzYW5m83MJaZV0P_nsnaVe2Jy9CodAGksw0mW8m028IGRsQVktrMhFAZ9x4lqEbITInQXPHNLBUReHpuXqY8ce5mG-V-oo5YR09cCe4G-2Ba8TIDGQ8YxKggjSsNEEbp4JITKBo87acqRRdQdRclWX_Q17kiLbrSM6dq2teDkxQYuofwMthcuSWtZkekP0eJtJJN7xDsuPbI_JRoFmkkxhrj8mjdIGe_1fitqVgG0c_LYTwvnQ0BlfpKzrYeOsK6lDnlzED45siSKU2TnuJOwldoTVqVrRpKdBlTAqn0DZv2HOqkHNMZtP7l7uHrK-YkNlo57OqEh5XZahsYU0wXASnfbCMW8WklsIrcEpZwHYmeFda5w0gpmI8x0aBlSdkt31v_SmhWhbBKS8ZXjwHZ3I0dSGXFhhUhSxGZLwRYv3REWPUXcaYrFHWdZR1zcsRuY0C_m0S2azTA9Rx3eu4_kvHI3KxUU_dLzHsAAeEAAT3qBGRA5UNOhu-aZtFotCOZ09KF2f_Mbpzshcn2-WPXZDd9erLXyJSWZur9FH-AByV6iw
  priority: 102
  providerName: Directory of Open Access Journals
Title 2061 Acellular hyaluronic acid scaffold with growth factor delivery for cartilage repair in a large animal model
URI https://www.proquest.com/docview/2136022307
https://pubmed.ncbi.nlm.nih.gov/PMC6798892
https://doaj.org/article/9ea494280a764375a8f7b03bf9bd8f54
Volume 2
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELZge-GCQIBYWiofeg04iRPbJ9SilkLVFUJU2ls0frWR0ux2uz303zOTeAu5IEWKklixMjOel7_MMHZkoXJGOZtVEUwmbRAZhhFV5hUY6YUBMXRRuFzU51fyx7JapoTbfYJV7nTioKj9ylGO_HORlzXaGxTJL-u7jLpG0e5qaqHxnO2hCtZ6xvZOThc_f_3NsqD3XJdl-jGPakW7LRXpzvUnWU5M0VCxf-JmTkGS_1ids1fsZXIX-fHI39fsWejfsHWB5pEfU86dQKT85hG6h6HGLQfXen7vIMZV5zklWfk1Btp4GhvrcB86QmI8cnRWuSO56VCj8A1apXbD254D7wgczqFvb3HmoVPOW3Z1dvr763mWOidkjux9VtdVwNUZa1c4G62sojchOiGdFsqoKmjwWjvAcTYGXzofLKBvJWSOg6Io37FZv-rDe8aNKqLXQQk8ZA7eIh-KmCsHAupCFXN2tCNisx4LZDQjckw1SOuGaN3Ics5OiMBPQ6iq9XBjtblu0iJpTABpMB4SoGg_sQIdlRWljcZ6HSs5Zwc79jRpqeEET4IxZ2rCsslk0yd9ezOU0qY9KG2KD_9_8T57QZ8xIsQO2Gy7eQgf0RfZ2sMkcIdDLI9X3y-W3xZ_APxX5a8
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELbK9gAXBALEQgEfyjHgOE4cHxBqodWWtiuEWqk342cbKWSX7VZo_xS_kZk8CrlwqxQpUmLZycxnz8PjGUJ2rcmdks4meTQqETawBMyIPPHSKOGZMqytonA6L2bn4stFfrFFfg9nYTCsclgT24XaLxz6yN_zNCtA3gAkPy5_Jlg1CndXhxIaHSyOw-YXmGzXH44-A3_fcn54cPZplvRVBRKHsjApijwAcmPhuLPRijx6FaJjwpVMKpmH0viydAba2Rh85nywBvQOJlJoFFkG_d4j2wI_Z0K29w_mX7_99eqAtl5kWX8QEHNTuzUmBU_LdyIbib62QsBIrR0HZf4j5Q4fkYe9ekr3Ojw9JluheUKWHMQx3UMfPwat0quNqW_anLrUuMrTa2diXNSeolOXXoJhD7eukA_1ocbIjw0F5Zg6xGkNKxhdgRSsVrRqqKE1BqNT01Q_YOS2Ms9Tcn4nNH1GJs2iCc8JVZJHXwbJ4BKp8Rb4zmMqnWGm4JJPye5ARL3sEnLoLlJNaqC1RlprkU3JPhL4tglm0W4fLFaXup-UWgUjFNhfzEjcv8xNGaVlmY3K-jLmYkp2BvbofmrDALdAnBI5YtlosPGbprpqU3fjnlep-Iv_d_yG3J-dnZ7ok6P58UvyAH-pi07bIZP16ia8Aj1obV_34KPk-13j_Q_kCyEQ
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELbKVkJcEAgQCwV8KMdQx3Fi-4BQS7tqKawqRKXegp9tpJBdtluh_Wv8OmbyKOTCrVKkSIkVK-PPnoc_zxCya03utHQ2yaPRibCBJeBG5ImXRgvPtGFtFYUv8-L4XHy6yC-2yO_hLAzSKoc1sV2o_cJhjHyPp1kB-gYguRd7WsTZ4ezD8meCFaRwp3Uop9FB5DRsfoH7dv3-5BDG-i3ns6NvH4-TvsJA4lAvJkWRB0BxLBx3NlqRR69DdEw4xaSWeVDGK-UMtLMx-Mz5YA3YIEyk0CiyDL57j2xL9IomZPvgaH729W-EByz3Isv6Q4GYp9qtMUF4qt6JbKQG22oBIxN3TND8R-PNHpGHvalK9ztsPSZboXlClhxUM93HeD8SWOnVxtQ3bX5dalzl6bUzMS5qTzHASy_ByYdbV9SH-lAjC2RDwVCmDjFbw2pGV6ARqxWtGmpojcR0aprqB_TcVul5Ss7vRKbPyKRZNOE5oVry6FWQDC6RGm8BAzym0hlmCi75lOwOQiyXXXKOsmOtyRJkXaKsS5FNyQEK-LYJZtRuHyxWl2U_QUsdjNDgizEjcS8zNypKyzIbtfUq5mJKdobhKftpDh3cgnJK5GjIRp2N3zTVVZvGG_e_lOYv_v_hN-Q-4Lz8fDI_fUke4B91RLUdMlmvbsIrMInW9nWPPUq-3zXc_wDeOSVF
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=2061+Acellular+hyaluronic+acid+scaffold+with+growth+factor+delivery+for+cartilage+repair+in+a+large+animal+model&rft.jtitle=Journal+of+clinical+and+translational+science&rft.au=Mart%C3%ADn%2C+Anthony+R&rft.au=Patel%2C+Jay+M&rft.au=Zlotnick%2C+Hannah+M&rft.au=Sennet%2C+Mackenzie+L&rft.date=2018-06-01&rft.pub=Cambridge+University+Press&rft.eissn=2059-8661&rft.volume=2&rft.issue=S1&rft.spage=3&rft.epage=3&rft_id=info:doi/10.1017%2Fcts.2018.43&rft.externalDBID=HAS_PDF_LINK
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2059-8661&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2059-8661&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2059-8661&client=summon